"The excimer laser, best know for its use in eye surgery is now being used to treat psoriasis. Of those who complete the study 84% showed at least a 75% improvement in 10 or fewer treatments."

"The new news is the XTRAC Excimer laser which is a targeted beam of light which allows for precise phototherapy of the psoriatic plaque."

CLOSE X

Why we need this

Call the number listed or fill out this form and one of our XTRAC specialists will get in touch with you. There is no pressure and no selling and your privacy is very important to us. We will not share your information with any unauthorized 3rd parties. Due to complex insurance regulations and a large number of treatment facilities it is important that one of our XTRAC specialists is able to speak with you and allow our team to work on your behalf for rapid insurance approval and quick results for the patient.

CLOSE X

Clinical Studies on XTRAC

XTRAC has been cited on over 45 clinical studies and research programs with findings published in peer-reviewed medical journals around the world. Two specific studies about XTRAC:

Efficacy of the 308-nm excimer laser for treatment of psoriasis:
Results of a multicenter study

From the Departments of Dermatology and Public Health Sciences, Wake Forest University School of Medicine, Winston-Salem; Dermatology Associates, Encinitasc; Laser and Skin Surgery Center of New York, New York City; Lehigh Valley Dermatology, Bethlehem; and Johns Hopkins at Green Spring, Lutherville.

Published by the American Academy of Dermatology

Of patients meeting clinical study protocol requirements:

  • 84% reached improvement of 75% or better after 10 or fewer treatments
  • 50% reached improvement of 90% or better after 10 or fewer treatments

"The XTRAC appears to have considerable advantages over other available treatment modalities for psoriasis, including fewer treatments to achieve results, and the added safety of site-specific dosing without exposure to healthy skin. In addition, this study has shown the XTRAC to be well tolerated and effective in treating thick, scaled plaques on the knees and elbows, which are often resistant to treatment."

Click to download full study

Effective treatment of scalp psoriasis using the excimer (308nm) laser From Johns Hopkins at Green Spring Station

Published by the Journal of Photodermatology, Photoimmunology & Photomedicine

"The XTRAC is a successful approach to treatment of psoriasis of the scalp in that it is a simple treatment that can be performed in a short period of time and which has a high rate of effectiveness. All patients in the study noticed improvement in their scalp psoriasis and 49% of the patients obtained a greater than 95% improvement."

Click to download full study

Contact Us Now!

For our NO COST treatment program!

We'll help you find a doctor
close to home or work.

Call 1-800-974-8958

Have your insurance information ready.

Or fill out the form below for more information
()
  • Over 2 Million Treatments Performed.
  • Clinical Results
  • Convenient Appointments

START NOW to LIVE CLEAR 1-800-974-8958

Have your insurance information ready.

How It Works

Using a carefully focused beam of laser light delivered through a sophisticated liquid light guide delivery system, the XTRAC system is designed to clear unsightly psoriatic skin plaques quickly and effectively. Because it concentrates light on active lesions, XTRAC allows your health care technician to deliver the high therapeutic doses necessary for rapid clearing without risk to healthy skin.

The Development of XTRAC

For decades, dermatologists have used ultra-violet light therapy for the effective and safe treatment of many skin disorders, including psoriasis. The medical engineers and research teams at PhotoMedex in coordination with Rox Anderson, M.D. at Harvard Medical School and Wellman Center of PhotoMedicine in Boston, created the XTRAC to produce a monochromatic wavelength (308nm) of ultraviolet light known to positively impact the psoriasis action spectrum.

Backed by Science

XTRAC has been cleared by the FDA and cited in over 45 clinical studies and research programs with findings published in peer-reviewed medical journals around the world. XTRAC is also endorsed by the National Psoriasis Foundation and the technology is part of the approved clinical protocols recommended by the American Academy of Dermatology. Over 2 million XTRAC treatments have been performed by leading dermatologists around the world and with excellent patient results.
Read more about XTRAC Clinical Studies

 

 

 

 

Psoriasis patients only.

*Side Effects/Risks: XTRAC has none of the drawbacks often associated with other psoriasis treatments-such as premature aging of healthy skin, skin thinning, resistance to medication, or potential negative systemic side effects. Some patients, however, experience a reaction similar to sunburn or blistering at the site of the treated area and in some cases, an increase in pigmentation may occur.

**Results may vary, talk to your doctor about the right treatment protocol for you.